Human Pathology
Volume 38, Issue 2 , Pages 197-204 , February 2007

Identification of a basal-like subtype of breast ductal carcinoma in situ

  • Chad A. Livasy, MD

      Affiliations

    • Department of Pathology and Lab Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • Corresponding Author InformationCorresponding author. Department of Pathology and Lab Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA.
    • ,
  • Charles M. Perou, PhD

      Affiliations

    • Department of Pathology and Lab Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • Department of Genetics, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • ,
  • Gamze Karaca, MSc

      Affiliations

    • Department of Genetics, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • ,
  • David W. Cowan, BS

      Affiliations

    • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • ,
  • Diane Maia, MD

      Affiliations

    • Department of Pathology and Lab Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • ,
  • Susan Jackson, MPA

      Affiliations

    • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • ,
  • Chiu-Kit Tse, MSPH

      Affiliations

    • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • ,
  • Sarah Nyante, MSPH

      Affiliations

    • Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • ,
  • Robert C. Millikan, PhD, DVM

      Affiliations

    • Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7525, USA
    • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7525, USA

Received 7 July 2006 ,Revised 23 August 2006 ,Accepted 24 August 2006.

References 

  1. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–752
  2. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–10874
  3. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418–8423
  4. Sotiriou C, Powles TJ, Dowsett M, et al. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res. 2002;4:R3
  5. van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–536
  6. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999–2009
  7. Ma XJ, Wang Z, Ryan PD, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell. 2004;5:607–616
  8. Huang E, Cheng SH, Dressman H, et al. Gene expression predictors of breast cancer outcomes. Lancet. 2003;361:1590–1596
  9. Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population based study. Proc Natl Acad Sci U S A. 2003;100:10393–10398
  10. Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A. 1999;96:9212–9217
  11. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367–5374
  12. Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003;95:1482–1485
  13. van de Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002;161:1991–1996
  14. Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol. 2004;203:661–671
  15. Kesse-Adu R, Shousha S. Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma. Mod Pathol. 2004;17:646–652
  16. Korsching E, Packeisen J, Agelopoulous K, et al. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest. 2002;82:1525–1533
  17. Tsuda H, Takarabe T, Hasegawa T, Murata T, Hirohashi S. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones. Hum Pathol. 1999;10:1134–1139
  18. Tsuda H, Takarabe T, Hasegawa F, Fukutomi T, Hirohashi S. Large, central acellular zones indicating myoepithelial tumor differentiaton in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol. 2000;24:197–202
  19. Newman B, Moorman PG, Millikan R, et al. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat. 1995;35:51–60
  20. Aldrich TE, Vann D, Moorman PG, Newman B. Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat. 1995;35:61–64
  21. Millikan RC, Pittman GS, Newman B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomark Prev. 1998;7:371–378
  22. The Consensus Conference Committee . Consensus conference on the classification of ductal carcinoma in situ. Cancer. 1997;80:1798–1802
  23. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155–168
  24. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492–2502
  25. Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19:264–271
  26. Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with a basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006;19:617–621
  27. Ernster VL, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr. 1997;22:151–156
  28. Ernster VL, Ballar-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94:1546–1554
  29. Solin LJ, Yeh IT, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer. 1993;71:2532–2542
  30. Chan KC, Know WF, Gee JM, et al. Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast. Cancer Res. 2002;62:122–128
  31. Lu C, Speers C, Zhang Y, et al. Effect of epidermal growth factor inhibitor on development of estrogen receptor-negative mammary tumors. J Natl Cancer Inst. 2003;95:1825–1833

☆ This work was supported by an award to the University of North Carolina for a Breast Cancer Specialized Program of Research Excellence (SPORE) from the National Cancer Institute, Bethesda, MD (CA58223), by the NCI (RO1-CA-101227-01) to C.M.P., and by the Breast Cancer Research Foundation, New York, NY.

PII: S0046-8177(06)00534-X

doi: 10.1016/j.humpath.2006.08.017

Human Pathology
Volume 38, Issue 2 , Pages 197-204 , February 2007

Article Tools

* Image Usage & Resolution